Litcius/Paper detail

Breast Implant Illness: Treatment Using Total Capsulectomy and Implant Removal.

Stephen E. Metzinger, Christopher Homsy, Magnus Chun, Rebecca C Metzinger

2022PubMed28 citationsOpen Access PDF

Abstract

Background: Breast implant illness (BII) is extramammary systemic symptoms that are caused by breast implants. The emergence of this controversial topic has spurred patients with breast implants who are experiencing these symptoms to seek implant removal, hoping to feel better. This article presents novel outcomes and suggestions for plastic surgeons in managing BII using total capsulectomy and breast implant removal. Methods: In this retrospective cohort study conducted between 2016 and 2020, medical records of all patients undergoing breast implant removal were reviewed. Inclusion criteria consisted of all patients with history of breast implant placement presenting with mastodynia and capsular contracture on physical examination. Patients with history of implant-based reconstruction following mastectomy and patients who underwent implant exchange were excluded. All patients underwent bilateral implant removal and total capsulectomies. Results: (49.6%). There were no associations between implant characteristics and rate of positive microbiology findings. Conclusions: Our study shows that implant removal with capsulectomy drastically improves BII symptoms. Further large prospective cohort studies are needed to better understand this entity.

Topics & Concepts

MedicineImplantBreast implantCapsular contractureBreast augmentationProspective cohort studySurgeryRetrospective cohort studyDentistryBreast cancerBreast reconstructionInternal medicineCancerBreast Implant and ReconstructionOrgan and Tissue Transplantation ResearchBreastfeeding Practices and Influences
Breast Implant Illness: Treatment Using Total Capsulectomy and Implant Removal. | Litcius